Gene expression for suppressors of telomerase activity (telomeric-repeat binding factors) in breast cancer.
about
Up-regulation of telomere-binding proteins, TRF1, TRF2, and TIN2 is related to telomere shortening during human multistep hepatocarcinogenesisThe expression of gene transcripts of telomere-associated genes in human breast cancer: correlation with clinico-pathological parameters and clinical outcome.Telomere-mediated genomic instability and the clinico-pathological parameters in breast cancer.Identification of differentially expressed genes in mouse hepatocarcinoma ascites cell line with low potential of lymphogenous metastasis.Over-expression of telomere binding factors (TRF1 & TRF2) in renal cell carcinoma and their inhibition by using SiRNA induce apoptosis, reduce cell proliferation and migration invitro.Novel perspective: focusing on the X chromosome in reproductive cancers.The telomerase cycle: normal and pathological aspects.Low-level infrared laser modulates muscle repair and chromosome stabilization genes in myoblasts.ERCC1 and telomere status in breast tumours treated with neoadjuvant chemotherapy and their association with patient prognosisReduced expression of TRF1 is associated with tumor progression and poor prognosis in oral squamous cell carcinoma.Telomere-driven diseases and telomere-targeting therapies.Specific overexpression of OLFM4(GW112/HGC-1) mRNA in colon, breast and lung cancer tissues detected using quantitative analysis.Differential senescence capacities in meibomian gland carcinoma and basal cell carcinoma.Telomerase-dependent oncolytic adenovirus for cancer treatment.Effects of TIN2 on telomeres and chromosomes in the human gastric epithelial cell line GES-1.Expression of telomeric repeat binding factor 1 in non-small cell lung cancer.
P2860
Q24675780-6670D00D-74B4-46DB-888F-CFED6DF303E9Q33290215-BE3B103B-4D3B-4705-93C5-AE97B9BC9EF2Q33362465-173C351F-306C-49CD-B5E7-39D44F33B589Q33866359-8E4B7282-7ED6-4508-9108-2E589A6CA913Q35137998-FF9ADD01-B263-4CC8-BB13-6BD1D8577853Q35553879-6CB6F570-2161-4682-8F8C-F4ABC163F02EQ35998861-EA47F2A3-BC36-4966-AF41-A5B9D30143C0Q36028285-E3277A64-54E6-41E2-A755-4B91E76939C7Q36175526-9ABEE022-B616-47A8-883A-884ABE3053D6Q36230464-4B1672A2-7037-4195-A6BE-4B8B46C9C769Q39158816-660020A1-B453-4119-941E-E0EE1E79A93BQ40176090-9A9A6419-34DD-47AD-A82B-0A6A46286429Q42483277-A4B7624C-A490-4533-9486-98EA11028FE0Q45863661-C0EB6672-C906-46BB-BE86-562A1DE7F991Q52649725-E8E30216-A3B6-408C-A733-0F1B40466BCAQ53714310-A3FF6296-E795-4278-B052-BE31988093B9
P2860
Gene expression for suppressors of telomerase activity (telomeric-repeat binding factors) in breast cancer.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Gene expression for suppressor ...... ing factors) in breast cancer.
@en
Gene expression for suppressors of telomerase activity
@nl
type
label
Gene expression for suppressor ...... ing factors) in breast cancer.
@en
Gene expression for suppressors of telomerase activity
@nl
prefLabel
Gene expression for suppressor ...... ing factors) in breast cancer.
@en
Gene expression for suppressors of telomerase activity
@nl
P2093
P2860
P1476
Gene expression for suppressor ...... ing factors) in breast cancer.
@en
P2093
Atsuhito Yagihashi
Daisuke Kobayashi
Kaori Saito
Masashi Nakamura
Naoki Tsuji
Naoki Watanabe
Shunichi Nasu
Yoko Izawa
P2860
P304
P356
10.1111/J.1349-7006.2002.TB02166.X
P577
2002-03-01T00:00:00Z